首页|期刊导航|中国临床药理学与治疗学|催乳颗粒通过调控WTAP-Wnt5a-β-catenin信号轴改善溴隐亭诱导的大鼠产后缺乳

催乳颗粒通过调控WTAP-Wnt5a-β-catenin信号轴改善溴隐亭诱导的大鼠产后缺乳OA

Cuiru Keli improves bromocriptine-induced postpartum hypogalactia in rats by regulating the WTAP-Wnt5a-β-catenin signaling axis

中文摘要英文摘要

目的:探讨催乳颗粒(Cuiru Keli,CRKL)对溴隐亭诱导的产后缺乳大鼠的疗效以及作用机制.方法:在产后缺乳大鼠模型中采用 ELISA 检测乳腺组织(mammary tissue,MT)中催乳素(prolactin,PRL)的水平.体外培养大鼠乳腺上皮细胞(rat mammary epithelial cells,RMECs).CCK-8法检测 CRKL 对 RMECs 增殖的影响来确定含药血清剂量.RT-qPCR 和免疫荧光检测乳糖乳脂乳蛋白相关基因的表达.网络药理学预测CRKL 治疗产后缺乳的信号通路.分子对接和分子动力学验证 CRKL 关键成分与肾母细胞瘤 1相关蛋白(WTAP)的结合.RNA 免疫沉淀法用于研究 WTAP 与 Wnt5a 间的相互作用.RT-qPCR 和Western blot 研究 CRKL 对 Wnt/β-catenin 信号通路的调节机制.结果:CRKL 显著提高母鼠单小时泌乳量(P<0.05或 P<0.01).CRKL 升高模型大鼠 MT 中 PRL 水平(P<0.01).含 CRKL 血清促进PRLR、FASN、CSN2、GLUT1的表达(P<0.05或 P<0.01).网络药理学预测 Wnt/β-catenin 信号通路与 CRKL 治疗产后缺乳高度相关.含 CRKL 血清促进 Wnt 信号通路关键基因 CCND1、c-Myc 和 β-catenin 的表达(P<0.05或 P<0.01).分子对接和分子动力学表明 CRKL 关键成分与 WTAP 的结合能力强.在RMECs 中过表达WTAP 干扰了CRKL的作用(P<0.01).结论:CRKL 通过WTAP-Wnt5a-β-catenin 信号轴改善溴隐亭诱导的大鼠产后缺乳.

AIM:To study the effect and mecha-nism of Cuiru Keli(CRKL)on bromocriptine-induced postpartum hypogalactia in rats.METHODS:ELISA was used to detect the level of prolactin(PRL)in mammary tissue(MT)of postpartum hypogalactia.Cultivate rat mammary epithelial cells(RMECs)in vitro.The effect of CRKL on RMEC proliferation was detected by CCK8 method to determine the drug-containing serum.RT-qPCR and immunofluores-cence detection of lactose,milk fat,and milk pro-tein related gene expression.Network pharmacolo-gy predicts the signaling pathway of CRKL treat-ment for postpartum hypogalactia.Molecular dock-ing and molecular dynamics verification of the bind-ing between key components of CRKL and WTAP.RIP was used to study the interaction between WTAP and Wnt5a.RT-qPCR and Western blot were used to investigate the regulatory mechanism of CRKL on the Wnt/β-catenin signaling pathway.RE-SULTS:CRKL significantly increased the hourly milk production of female rats(P<0.05 or P<0.01).CRKL increases PRL levels in MT of model rats(P<0.01).Serum containing CRKL promotes the expression of PRLR,FASN,CSN2,and GLUT1(all P<0.05 or P<0.01).Network pharmacology predicts a high cor-relation between the Wnt/β-catenin signaling path-way and CRKL treatment for postpartum hypogalac-tia.And the serum containing CRKL promotes the expression of key genes CCND1,c-Myc,and β-catenin in the Wnt signaling pathway(all P<0.05 or P<0.01).Molecular docking and molecular dynam-ics indicate that the key component of CRKL has strong binding ability with WTAP.Overexpression of WTAP in RMECs interferes with the function of CRKL(P<0.01).CONCLUSION:CRKL improves bromocrip-tine-induced postpartum hypogalactia in rats through the WTAP-Wnt5a-β-catenin signaling axis.

李慧;薛秋云;袁美玲;金奇盈;陈嘉庆;夏艾芯;许晨昊;缪成贵

安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽安徽中医药大学新安医学与中医药现代化研究所,合肥 230012,安徽||安徽中医药大学中西医结合学院实验(实训)教学中心,合肥 230012,安徽安徽中医药大学中西医结合学院药理学教研室,合肥 230012,安徽||安徽中医药大学新安医学与中医药现代化研究所,合肥 230012,安徽||安徽中医药大学中西医结合学院实验(实训)教学中心,合肥 230012,安徽||香港大学李嘉诚医学院中医药学院,香港 999077,中国

医药卫生

催乳颗粒产后缺乳肾母细胞瘤1相关蛋白Wnt5a催乳素

Cuiru Kelipostpartum hypogalactiaWTAPWnt5aprolactin

《中国临床药理学与治疗学》 2026 (9)

1200-1213,14

合肥大健康研究院新安医学与中医药现代化研究所专项(2023CXMMTCM025)安徽省重点研究与开发计划(2022e07020028)安徽省教育厅研究项目(2024AH051026,gxgwfx2022019,2022xnfzkc023,2023jyxm0345)安徽中医药大学研究项目(2020rcZD001,2022BHTNXA05)安徽省中医药管理局研究项目(2022CCYB10)

10.12092/j.issn.1009-2501.2026.09.006

评论